COMPANY PROFILE

Molecule

Connects scientists with the funding needed for successful therapeutics development through blockchain powered crowdfunding

Berlin, GermanyFounded 2018Biotech & Life Sciences

Valuation $25–50M Last recorded · 2022

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Molecule

A decentralized biotech platform that connects scientists and researchers with investors to fund and advance novel research and intellectual property (IP).

Read full description

Molecule operates a marketplace for tokenized research, allowing for the creation of "Bio-DAOs" (Decentralized Autonomous Organizations) and the trading of "IP-NFTs" (Non-Fungible Tokens for Intellectual Property). This model aims to create a more equitable and efficient system for drug development and other areas of scientific research by providing new funding avenues and opportunities for collaboration.

The platform serves a dual market: researchers and scientists who are seeking funding for their projects, and investors who are looking for opportunities in early-stage biotech and life sciences. By tokenizing IP, Molecule allows for fractional ownership and easier transfer of research assets, which can accelerate the pace of innovation.

Its business model is centered around the creation and facilitation of this marketplace, where it likely takes a fee from transactions or the initial funding of projects. The company is at the forefront of the emerging DeSci (Decentralized Science) movement, which seeks to apply decentralized technologies to scientific research.

Source: Dealroom company data